Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.24.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Restricted Stock awards
Common Stock
Restricted Stock Units
Common Stock
Additional Paid-In Capital
Restricted Stock awards
Additional Paid-In Capital
Restricted Stock Units
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive (Loss)
Restricted Stock awards
Restricted Stock Units
Total
BALANCE at Dec. 31, 2020     $ 23     $ 844,188 $ (328,277) $ (9)     $ 515,925
BALANCE (in shares) at Dec. 31, 2020     224,626,597                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Exercise of Common Stock options     $ 1     6,425         6,426
Exercise of Common Stock options (in shares)     5,732,247                
Vesting of restricted Common Stock (in shares)     491,293                
Vesting of restricted share units (in shares)     650,777                
Repurchase of shares for employee tax withholdings       $ (958) $ (541)       $ (958) $ (541)  
Repurchase of shares for employee tax withholdings (in shares) (109,150) (61,498)                  
Issuance of Common Stock in connection with acquisitions     $ 5     620,585         620,590
Issuance of Common Stock in connection with acquisitions (in shares)     57,267,401                
Issuance of Common Stock in connection with acquired in-process research and development           4,300         4,300
Issuance of Common Stock in connection with acquired in-process research and development (in shares)     334,370                
Stock-based compensation expense           28,778         28,778
Vesting of Trine Founder shares (in shares)     1,850,938                
Common Stock issued in connection with warrants exercised     $ 2     320,567         320,569
Common stock issued in connection with warrants exercised (in shares)     20,690,975                
Net loss             (240,334)       (240,334)
Other comprehensive income (loss)               (6,405)     (6,405)
BALANCE at Dec. 31, 2021     $ 31     1,823,344 (568,611) (6,414)     1,248,350
BALANCE (in shares) at Dec. 31, 2021     311,473,950                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Exercise of Common Stock options           3,190         3,190
Exercise of Common Stock options (in shares)     2,310,931                
Vesting of restricted Common Stock (in shares)     157,131                
Vesting of restricted share units     $ 1               1
Vesting of restricted share units (in shares)     4,153,939                
Repurchase of shares for employee tax withholdings         (243)         (243)  
Repurchase of shares for employee tax withholdings (in shares)   (74,719)                  
Issuance of Common Stock related to settlement of contingent consideration           500         500
Issuance of Common Stock related to settlement of contingent consideration (in shares)     112,202                
Stock-based compensation expense           48,001         48,001
Net loss             (740,343)       (740,343)
Other comprehensive income (loss)               (31,954)     (31,954)
BALANCE at Dec. 31, 2022     $ 32     1,874,792 (1,308,954) (38,368)     527,502
BALANCE (in shares) at Dec. 31, 2022     318,133,434                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Exercise of Common Stock options           1,203         1,203
Exercise of Common Stock options (in shares)     1,006,046                
Vesting of restricted Common Stock (in shares)     95,859                
Vesting of restricted share units     $ 1     (1)          
Vesting of restricted share units (in shares)     5,802,852                
Repurchase of shares for employee tax withholdings         $ (250)         $ (250)  
Repurchase of shares for employee tax withholdings (in shares)   (211,314)                  
Issuance of Common Stock related to settlement of contingent consideration           797         797
Issuance of Common Stock related to settlement of contingent consideration (in shares)     444,793                
Stock-based compensation expense           31,963         31,963
Net loss             (323,271)       (323,271)
Other comprehensive income (loss)               3,708     3,708
BALANCE at Dec. 31, 2023     $ 33     $ 1,908,504 $ (1,632,225) $ (34,660)     $ 241,652
BALANCE (in shares) at Dec. 31, 2023     325,271,670